FX.co ★ Revvity Guides FY25 Below Estimates - Update

In its financial results announcement for the fourth quarter on Friday, biotechnology company Revvity, Inc. (RVTY) introduced its outlook for adjusted earnings and total revenue for the fiscal year 2025. The company forecasts adjusted earnings to range between $4.90 and $5.00 per share, with total revenue anticipated to fall between $2.80 billion and $2.85 billion. Analysts, on average, have predicted earnings to be $5.00 per share with revenues reaching $2.86 billion for the year. It is important to note that analysts' projections generally do not include special items.